Filing Details
- Accession Number:
- 0000059478-23-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-14 17:12:35
- Reporting Period:
- 2023-02-10
- Accepted Time:
- 2023-02-14 17:12:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 59478 | Eli Lilly & Co | LLY | Pharmaceutical Preparations (2834) | 350470950 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752313 | E. Anne White | Lilly Corporate Center Indianapolis IN 46285 | Evp & Pres, Lilly Neuroscience | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-10 | 8,562 | $345.12 | 62,926 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-02-10 | 2,500 | $342.76 | 60,426 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-13 | 2,500 | $346.47 | 57,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Acquisiton | 2023-02-10 | 4,124 | $0.00 | 4,124 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,124 | 2024-02-01 | 2024-02-01 | No | 4 | A | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022.
- Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Billionaire Hedge Funds
